3-carboxamide derivatives of 5h-pyrrolo2,1-c1,4-benzodiazepines
CA 2268327 C · Owner: Wyeth · Inventors: Molinari, Albert John; Bagli, Jehan Framroz; Ashwell, Mark Anthony
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
This invention relates to tricyclic non-peptide vasopressin antagonists which are useful in treating conditions where decreased vasopressin levels are desired such as in, congestive heart failure, in disease conditions with excess renal water reabsorption and in conditions with increased vascular resistance and coronary vasoconstriction the com-, pounds having general structure (I).
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 22, 1997 and granted May 21, 2002. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended October 22, 2017.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 22, 2019.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.